GEMAROMA Gem Aromatics Q2 FY26 results (Jul–Sep 2025) and concall
GEM Aromatics reported a challenging Q2 FY26 with revenue of ₹89.5 crores and a net loss of ₹2.6 crores, primarily due to external factors like US tariffs and domestic GST changes impacting demand and margins. Despite this, the company successfully completed its IPO, repaid ₹140 crores of debt, and is on track to commission its significant Phase-II Dahej plant by November 30th, aiming for long-term growth and product diversification into higher-margin specialty chemicals.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue down 20.2%, net profit down 126.5% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 112 | 97 | 202 | 88 | 90 −20% |
| EBITDA | 15 | 13 | 46 | 15 | 3 −80% |
| Net profit | 10 | 7 | 28 | 8 | -3 −126% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
